blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3856895

EP3856895 - BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.07.2021
Database last updated on 28.06.2024
FormerThe international publication has been made
Status updated on  05.04.2020
Most recent event   Tooltip27.09.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
BioVaxys Inc.
1177 Avenue of the Americas, 5th Floor
New York, NY 10036 / US
[N/P]
Former [2021/31]For all designated states
BioVaxys Inc.
1177 Avenue of the Americas 5th Floor
New York NY 10036 / US
Inventor(s)01 / BERD, David
125 Heacock Lane
Wyncote, PA 19095 / US
 [2021/31]
Representative(s)Plasseraud IP
66, rue de la Chaussée d'Antin
75440 Paris Cedex 09 / FR
[2021/31]
Application number, filing date19865684.524.09.2019
[2021/31]
WO2019US52644
Priority number, dateUS201862735381P24.09.2018         Original published format: US 201862735381 P
US201862746066P16.10.2018         Original published format: US 201862746066 P
[2021/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020068786
Date:02.04.2020
Language:EN
[2020/14]
Type: A1 Application with search report 
No.:EP3856895
Date:04.08.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 02.04.2020 takes the place of the publication of the European patent application.
[2021/31]
Search report(s)International search report - published on:US02.04.2020
(Supplementary) European search report - dispatched on:EP02.08.2022
ClassificationIPC:C12N5/09, C07K14/705, A61K35/13, A61K39/00
[2022/35]
CPC:
C07K14/70575 (EP,KR,US); A61K35/13 (EP,KR); A61K39/39541 (EP,KR,US);
A61K39/0011 (EP,KR); A61P35/04 (EP,KR); C07K14/705 (EP,KR);
C07K16/2818 (EP,KR,US); A61K2039/5152 (EP,KR); A61K2039/545 (EP,US);
A61K2039/55594 (EP); A61K2039/6012 (EP); A61K2039/70 (EP);
A61K2300/00 (KR) (-)
C-Set:
A61K35/13, A61K2300/00 (EP);
A61K39/0011, A61K2300/00 (KR,EP);
A61K39/39541, A61K2300/00 (EP)
Former IPC [2021/31]C12N5/09, C07K14/705, A61K35/13
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/31]
TitleGerman:BIHAPTENISIERTE AUTOLOGE IMPFSTOFFE UND IHRE VERWENDUNGEN[2021/31]
English:BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF[2021/31]
French:VACCINS AUTOLOGUES BIHAPTÉNISÉS ET LEURS UTILISATIONS[2021/31]
Entry into regional phase21.04.2021National basic fee paid 
21.04.2021Search fee paid 
21.04.2021Designation fee(s) paid 
21.04.2021Examination fee paid 
Examination procedure21.04.2021Examination requested  [2021/31]
28.02.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
21.04.2021Renewal fee patent year 03
27.09.2022Renewal fee patent year 04
27.09.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO0038710  (UNIV JEFFERSON [US], et al) [Y] 1-15 * abstract * * page 26, line 1 * * claims 1,9,12,18,30,31 *;
 [Y]US2015202291  (BOSCH MARNIX LEO [US], et al) [Y] 1-15* claims 1,9,20 *;
 [Y]  - KLEPONIS JENNIFER ET AL, "Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors", CANCER BIOLOGY & MEDICINE, TIANJIN YIKE DAXUE FUSHU ZHONGLIU YIYUAN,TIANJIN MEDICAL UNIVERSITY CANCER INSTITUTE AND HOSPITAL, CN, (20150901), vol. 12, no. 3, doi:10.7497/J.ISSN.2095-3941.2015.0046, ISSN 2095-3941, pages 201 - 208, XP008182450 [Y] 1-15 * abstract * * page 2 - page 5 *

DOI:   http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0046
 [Y]  - BERD D ED - GIERSING BIRGITTE K ET AL, "Autologous, hapten-modified vaccine as a treatment for human cancers", VACCINE, ELSEVIER, AMSTERDAM, NL, (20010321), vol. 19, no. 17-19, doi:10.1016/S0264-410X(00)00490-4, ISSN 0264-410X, pages 2565 - 2570, XP004231081 [Y] 1-15 * page 3, column 2 - page 4, column 1 *

DOI:   http://dx.doi.org/10.1016/S0264-410X(00)00490-4
 [Y]  - A. RIBAS ET AL, "Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma", CLINICAL CANCER RESEARCH, US, (20091001), vol. 15, no. 19, doi:10.1158/1078-0432.CCR-09-1254, ISSN 1078-0432, pages 6267 - 6276, XP055329094 [Y] 1-15 * abstract * * page 2, paragraph 2 * * page 4, paragraph 2 - page 5, paragraph 1 * * page 7, paragraph 1 * * page 8 - page 10 *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-09-1254
International search[Y]WO9640173  (UNIV JEFFERSON [US], et al) [Y] 17-21 * ; page 59, lines 21-23; page 61, line 20 *;
 [Y]WO9956773  (UNIV JEFFERSON [US], et al) [Y] 4/1-3, 5/1-3, 7-8 * ; page 16, line 26; page 31, lines 6-9; page 32, line 11 *;
 [Y]WO0038710  (UNIV JEFFERSON [US], et al) [Y] 1-3, 4/1-3, 5/1-3, 7-21 * ; page 21, lines 4-8; page 25, line 28 - page 26, line 12 *;
 [Y]WO2005080990  (ISTITUTO NAZ DELLE MALATTIE IN [IT], et al) [Y] 16 * ; page 5, paragraph 3; page 9, paragraph 4; page 26, paragraph 4; claim 25 *;
 [Y]US2013034580  (KHANDKE LAKSHMI [US], et al) [Y] 16 * ; paragraphs [0123], [0141] *;
 [Y]WO2015069770  (COGNATE BIOSERVICES INC [US], et al) [Y] 1-3, 4/1-3, 5/1-3, 7-15 * ; abstract; paragraphs [0011], [0083], [0089]; claims 6, 9-10 *;
 [Y]WO2015181220  (QIAGEN GMBH [DE]) [Y] 21* ; claims 1, 6 *;
 [Y]  - KAKOSCHKY, B et al., "Selective Targeting of Tumor Associated Macrophages in Different Tumor Models", PLoS One, (20180215), vol. 13, no. 2, pages 1 - 13, XP055701870 [Y] 17-21 * ; page 4/13, paragraph 3; DOI: 10.1371/journal.pone.0193015 *

DOI:   http://dx.doi.org/10.1371/journal.pone.0193015
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.